Wed, July 12, 2017
Tue, July 11, 2017
Mon, July 10, 2017
Fri, July 7, 2017
Thu, July 6, 2017
Wed, July 5, 2017
Mon, July 3, 2017

David Lebovitz Maintained (ALNY) at Hold with Increased Target to $46 on, Jul 10th, 2017

David Lebovitz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold with Increased Target from $42 to $46 on, Jul 10th, 2017.

David has made no other calls on ALNY in the last 4 months.



There are 2 other peers that have a rating on ALNY. Out of the 2 peers that are also analyzing ALNY, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Esther Rajavelu of "UBS" Initiated at Hold and Held Target at $55 on, Thursday, March 30th, 2017


This is the rating of the analyst that currently disagrees with David


  • Do Kim of "BMO Capital" Initiated at Buy and Held Target at $73 on, Monday, April 17th, 2017